HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Javier González-Maeso Selected Research

volinanserin

6/2022Effects of the 5-HT2A receptor antagonist volinanserin on head-twitch response and intracranial self-stimulation depression induced by different structural classes of psychedelics in rodents.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Javier González-Maeso Research Topics

Disease

25Schizophrenia (Dementia Praecox)
08/2021 - 03/2008
9Psychotic Disorders (Schizoaffective Disorder)
01/2019 - 03/2008
4Hallucinations (Hallucination)
06/2022 - 12/2009
4Mental Disorders (Mental Disorder)
01/2018 - 06/2013
2Mood Disorders (Mood Disorder)
11/2018 - 04/2006
1Substance-Related Disorders (Drug Abuse)
06/2022
1Cognitive Dysfunction
01/2020
1Infections
01/2020
1Cardiovascular Diseases (Cardiovascular Disease)
01/2017
1Major Depressive Disorder (Major Depressive Disorders)
11/2014
1Night Terrors (Sleep Terror)
11/2013
1Neurobehavioral Manifestations
11/2013
1Dementia (Dementias)
11/2011
1Virus Diseases (Viral Diseases)
02/2011
1Nervous System Diseases (Neurological Disorders)
11/2010
1Parkinson Disease (Parkinson's Disease)
12/2006
1Bipolar Disorder (Manic Depressive Psychosis)
04/2006

Drug/Important Bio-Agent (IBA)

16Antipsychotic Agents (Antipsychotics)IBA
08/2021 - 04/2009
14Serotonin (5 Hydroxytryptamine)IBA
01/2020 - 03/2008
95-HT2A Serotonin Receptor (5 HT2A Receptor)IBA
01/2020 - 02/2011
9Glutamic Acid (Glutamate)FDA Link
01/2019 - 04/2009
7Lysergic Acid Diethylamide (LSD)IBA
06/2022 - 03/2008
6Hallucinogens (Psychedelics)IBA
06/2022 - 03/2008
5Clozapine (Clozaril)FDA LinkGeneric
01/2021 - 12/2009
5G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
11/2018 - 04/2006
3Dopamine (Intropin)FDA LinkGeneric
08/2021 - 09/2011
3Proteins (Proteins, Gene)FDA Link
12/2019 - 11/2014
3Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA
02/2011 - 03/2008
2Neurotransmitter Agents (Neurotransmitter)IBA
01/2019 - 11/2018
2Haloperidol (Haldol)FDA LinkGeneric
01/2018 - 12/2009
2Phencyclidine (Angel Dust)IBA
11/2013 - 04/2009
2Psilocybin (Psilocibin)IBA
02/2011 - 03/2008
2metabotropic glutamate receptor 2IBA
12/2009 - 03/2008
14-iodo-2,5-dimethoxyphenylisopropylamine (DOI-P)IBA
06/2022
1tryptamineIBA
06/2022
1phenethylamineIBA
06/2022
1volinanserinIBA
06/2022
1ErgolinesIBA
06/2022
1GTP-Binding Proteins (G-Protein)IBA
08/2021
1Dopamine D2 Receptors (Dopamine D2 Receptor)IBA
08/2021
1Anti-Bacterial Agents (Antibiotics)IBA
01/2020
1Messenger RNA (mRNA)IBA
12/2019
1EndocannabinoidsIBA
11/2018
1CannabinoidsIBA
11/2018
1CB1 Cannabinoid Receptor (CB1 Receptor)IBA
11/2018
1LigandsIBA
01/2018
1Biogenic Amines (Biogenic Amine)IBA
01/2018
1Calcium Channels (Calcium Channel)IBA
01/2017
1Calcium Channel Blockers (Blockers, Calcium Channel)IBA
01/2017
1Nifedipine (Adalat)FDA LinkGeneric
01/2017
1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
08/2015
1Serotonin ReceptorsIBA
07/2015
1Antidepressive Agents (Antidepressants)IBA
11/2014
1efavirenz (Sustiva)FDA Link
11/2013
1KetanserinIBA
08/2013
1Histone Deacetylase InhibitorsIBA
09/2012
1Mescaline (Peyote)IBA
02/2011
1Pharmaceutical PreparationsIBA
11/2010
1metabotropic glutamate receptor 3 (mGluR3)IBA
12/2009
1Glutamate Receptors (Glutamate Receptor)IBA
03/2008
1Proteasome Endopeptidase Complex (Proteasome)IBA
12/2006
1Proteasome InhibitorsIBA
12/2006
1Heterotrimeric GTP-Binding Proteins (Heterotrimeric G-Proteins)IBA
04/2006

Therapy/Procedure

2Therapeutics
03/2017 - 02/2011
1Drug Therapy (Chemotherapy)
01/2013